Entrar/Registro  
HOME SPANISH
 
Cirugía y Cirujanos
   
MENU

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board






>Journals >Cirugía y Cirujanos >Year 2004, Issue 4


Carrillo-Esper R, Contreras-Domínguez V
Pseudothrombocytopenia induced by ethylenediaminetetraacetic acid in burn patients
Cir Cir 2004; 72 (4)

Language: Español
References: 25
Page: 335-338
PDF: 88.53 Kb.


Full text




ABSTRACT

The EDTA-dependent pseudothrombocytopenia is a false decrease in the number of platelets below the normal value when analyzed with automated devices. There is an incidence of 0.09 to 0.21% in hospitalized patients. Pseudothrombocytopenia is secondary to platelet clumping induced by antibodies in the presence of EDTA and has been associated with sepsis, cancer, cardiac surgery and drugs. We report the first case of pseudothrombocytopenia induced by EDTA in a burn patient.


Key words: Pseudothrombocytopenia, Ethylenediaminetetraacetic acid (EDTA).


REFERENCIAS

  1. Gelinas JP, Stoddart LV, Zinder EL. Thrombocytopenia and critical care medicine. J Intensive Care Med 2001;16:1-21.

  2. Bragnani G, Bianconcini G, Brogna R, Zoli G. Pseudothrombocytopenia: clinical comment on 37 cases. Minerva Med 2001;92:13-17.

  3. García SJ, Merino JL, Rodríguez M, et al. Pseudothrombocytopenia: incidence, causes and methods of detection. Sangre 1991; 36: 197-200.

  4. Payne BA, Pierre RV. Pseudothrombocytopenia: a laboratory artifact with potentially serious consequences. Mayo Clin Proc 1984;59:123-125.

  5. Sweeney JD, Holme S, Heaton WA, et al. Pseudothrombocytopenia in plateletpheresis donors. Transfusion 1995;35:46-49.

  6. Cohen AM, Cycowitz Z, Mittelman M, et al. The incidence of pseudothrombocytopenia in automatic blood analyzers. Hematologia (Budap) 2000;30:1117-1721.

  7. Bizarro N. EDTA-dependent pseudothrombocytopenia: a clinical and epidemiological study of 112 cases, with 10-year follow-up. Am J Hematol 1995;50:103-109.

  8. Berkman N, Michaeli Y, Eldor A. EDTA-dependent pseudothrombocytopenia: a clinical study of 18 patients and a review of the literature. Am J Hematol 1991;36:195-201.

  9. Pegels JG, Bruynes ECE, Engelfriet CP, Von Dem Borne AEGK. Pseudothrombocytopenia. An immunological study on platelet antibodies on ethylene diamine tetraacetate. Blood 1982:59:157-161.

  10. Casonato A, Bertomoro A, Pontara E, et al. EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA. J Clin Pathol 1994;47:625-630.

  11. Watkins SP, Shulman NR. Platelet cold agglutinins. Blood 1970; 36:153-158.

  12. Veen Hoven WA, Van Der Schans G, Huiges W, et al. Pseudothrombocytopenia due to agglutinins. Am J Clin Pathol 1979;72:1005-1008.

  13. De Caterina M, Fratellanza G, Grimaldo E. Evidence of a cold immunoglobin M autoantibody against 78 kD platelet glycoprotein in a case of EDTA-dependent pseudothrombocytopenia. Am J Clin Pathol 1993;99:163-167.

  14. Van der Meer W, Allebes W, Simon A, et al. Pseudothrombocytopenia: a report of a new method to count platelets in a patient with EDTA and temperature-independent antibodies of the IgM type. Eur J Haematol 2002;69:243-247.

  15. Bizarro N, Brandalise M. EDTA-dependent pseudothrombocytopenia. Association with antiplatelet and antiphospholipid antibodies. Am J Clin Pathol 1995;103:103-107.

  16. Yoneyama A, Nakahara K. EDTA-dependent pseudothrombocytopenia— differentiation from true thrombocytopenia. Nippon Rinsho 2003;61:569-574.

  17. Barteles PC, Schoorl M, Lombarts AJ. Screening for EDTA-dependent deviations in platelet counts and abnormalities in platelet distribution histograms in pseudothrombocytopenia. Scand J Clin Lab Invest 1997;57:629-636.

  18. Morales M, Moreno A, Mejía M, et al. Pseudotrombocitopenia EDTA-dependiente: rol del laboratorio clínico en la detección y correcto contaje plaquetario. RFM 2001;24:798-805.

  19. Moll S, Poepping I, Hauck S, et al. Pseudothrombocytopenia after abciximab (ReoPro) treatment. Circulation 1999;100:1460-1462.

  20. Barr RD, Copeland SA, Stockwell ML, et al. Valproic acid and immune thrombocytopenia. Arch Dis Child 1982;57:681-684.

  21. Sandler RM, Emberson C, Roberts GE, et al. IgM platelet autoantibody due to sodium valproate. Br Med J 1978;2:1683-1684.

  22. Yoshikawa H. EDTA-dependent pseudothrombocytopenia induced by valproic acid. Neurology 2003;61:579-580.

  23. Girmann G, Pees H, Shuerlen PG. Pseudothrombocytopenia and mexiletine. Ann Intern Med 1984;100:767.

  24. Mori M, Kudo H, Yoshitake S, et al. Transient EDTA-dependent pseudothrombocytopenia in a patient with sepsis. Intensive Care Med 2000;26:218-220.

  25. Dalamangas LC, Slaughter TF, Thomas F. Ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia in a cardiac surgical patient. Anesth Analg 1998;86:1210-1211.






>Journals >Cirugía y Cirujanos >Year 2004, Issue 4
 

· Journal Index 
· Links 






       
Copyright 2019